A Single and Multiple Ascending Dose Study With AZD9164 Given for 13 Days in Healthy Male and Female Japanese Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Healthy
Interventions
DRUG

AZD9164

"Dry powder for inhalation via Turbuhaler, JSMAD. A single dose of AZD9164 on Day 1 and repeated dosing on Day 4 to day 15 (JSMAD).~The starting dose will be 400 μg delivered dose and subsequent doses are planned to be 1000 μg and 2800 μg delivered dose."

DRUG

Placebo

Dry powder for inhalation via Turbuhaler, JSMAD.

Trial Locations (1)

Unknown

Research Site, Croydon

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY